Relationship contracts with industry and society from 2020

Contract conclusion year	Contract amount (Rials)	Employer	Executive	Title	Row
2020	389/700/000	Standard General Directorate of Kermanshah	Dr. Reza Mohammadi	Investigating the Physico-chemical characteristics, heavy metals, synthetic color, fatty acid profile and microbiological characteristics of rice bread produced in Kermanshah province in 2020-2021	1
2020	500/000/000	Shari pharmaceutical industry	Dr. Gholamreza Bahrami	Biocompatibility study of tenofovir alafenamide 25 mg tablets manufactured by Shari pharmaceutical industry with Vemlidy 25 mg tablets manufactured by Gilead Sciences Ltd	2
2020	500/000/000	Shari pharmaceutical industry	Dr. Gholamreza Bahrami	Biocompatibility study of Sofosbuvir/Volpatasvir 100/400 mg combination tablet manufactured by Shari pharmaceutical industry with Epclusa 400/100 mg tablet manufactured by Gilead Sciences Ltd	3
2020	300/000/000	Varian Pharmed research and production company	Dr. Gholamreza Bahrami	Formulation of extraction and analysis method of three drugs triptorelin acetate, triptorelin pamoate and leuprolide acetate in human plasma by LC-mass-mass method along with validation by application in bioequivalence studies	4
2020	220/000/000	Behsaz Ghazaye Zagros Company	Dr. Ehsan Sadeghi	Production of two types of useful canned goods	5
2020	According to the comprehensive laboratory tariff	Dr. Elham Arkan	Faculty of Pharmacy	Benefiting from semi-industrial electrospinning laboratory services/equipment for the production of nanofibers	6
2020	250/000/000	Bahar Dalahu Manizan Company	Dr. Ehsan Sadeghi	Prototype production of vitamin D-enriched probiotic with reduced calories	7
2020	410/000/000	Razi Applied Biotechnology Center	Dr. Bijan Soleimani	Production of fructosyl peptide recombinant protein on the laboratory scale	8
2020	45/376/000	Bu-Ali Daru Pharmaceutical Company	Dr. Mansour Rezaei	A comparative study of the effect of Morr herbal capsule and placebo on primary dysmenorrhoea pains	9
2020	100/000/000	Ilam University of Basic Sciences	Dr. Fatemeh Khademi	Investigating the anti-inflammatory effect of placenta extract of the oak plant (Quercus brnatii) on cervical disc inflammation model (cervical spondylosis) and acute and chronic inflammatory model in rats	10
2020	210/460/000	Ilam University of Basic Sciences	Dr. Fatemeh Khademi	Investigating the anti-inflammatory mechanism of placental extract of the oak plant (Quercus brnati) on the signaling pathway of NFkB-p65 and the expression of cytokines IL-1B and TNF-a in a rat cervical spondylosis model	11
2020	79/660/000	Bu-Ali Daru Pharmaceutical Company	Dr. Mansour Rezaei	A comparative study on the effect of sodium valproate and Sodae herbal capsule on migraine headaches	12
2020	500/000/000	Shari pharmaceutical industry	Dr. Gholamreza Bahrami	Conducting a biocompatibility study of Emtricitaf combination tablet (emtricitabine 200/ tenofovir alafenamide manufactured by Shari pharmaceutical industry) with Descovy 25/200 tablet manufactured by Gilead Sciences Ltd	13
2020	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Conducting a biocompatibility study of favipiravir 200 mg tablets manufactured by Bakhtar Biochemical Company with favipiravir 200 mg tablets manufactured by Zhejiang Hisun factory	14
2020	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Conducting a biocompatibility study of ribabaiovir 600 mg tablets manufactured by Bakhtar Biochemical Company with Rebetol 600 mg manufactured by Merck, Germany	15
2020	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Conducting a bioequivalence study of the combined tablet of Efavirenz 600/ Emtricitabine 200/ Tenofovir disoproxil 300 manufactured by Bakhtar Biochemistry Company with ATRIPLA 600/200/300 mg manufactured by Gilead Sciences and Bristol-Myers Squibb.	16
2020	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Conducting a biocompatibility study of Dolutegravir 50 mg tablet manufactured by Bakhtar Biochemical Company with Tivicay 50 mg tablet manufactured by Glaxo Smithkline factory	17
2020	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	A biocompatibility study of lopinavir/ritonavir 50/200 mg combination tablet manufactured by Bakhtar Biochemical Company with Aluvia tablet manufactured by Glaxo Smithkline 200/50 mg	18
2020	500/000/000	Shari pharmaceutical industry	Dr. Gholamreza Bahrami	A biocompatibility study of Entecavir Shari 1 mg tablet manufactured by Shari Pharmaceutical Industry Company with Baraclude 1 mg tablet manufactured by Bristol-Myers Squibb factory	19


2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of Sitagliptin/Metformin 50/500 mg tablets manufactured by Bakhtar Biochemistry Company with Janumet tablets manufactured by MSD factory	1
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of sitagliptin 50 mg tablet manufactured by Bakhtar Biochemistry company with Januvia tablet manufactured by MSD factory	2
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of bosentan 125 mg tablet made by Bakhtar Biochemistry company with Tracleer 125 mg tablet made by Actelion factory	3
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of Daclatasvir 60 mg tablet manufactured by Bakhtar Biochemistry Company with Daklinza 60 mg tablet manufactured by Bristol-Myers Squibb Pharma.	4
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of Zaleplon 10 mg tablet manufactured by Bakhtar Biochemical Company with Sonata 10 mg tablet manufactured by Pfizer factory	5
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of Sodaquir 400/60 tablets (Daclatasvir 60 / Sofosbuvir 400) milligram manufactured by Bakhtar Biochemical Company with Daklinza 60 mg tablets manufactured by Bristol-Myers Squibb Pharma / Sovaldi 400 mg manufactured by Gilead factory	6
2021	500/000/000	Bakhtar Biochemistry Co	Dr. Gholamreza Bahrami	Biocompatibility study of Valsartan HCT 160/25 mg tablets manufactured by Bakhtar Biochemical Company with Valsartan HCT tablets manufactured by Sandoz factory	7
2021	278/160/000	Kermanshah General Department of Forensic Medicine	Dr. Kheirollah Yari	Using Ketcher's method to extract diazepam, clonazepam and alprazolam drugs from the liver and comparing it with the liquid-liquid extraction method.	8
2021	300/000/000	Rojin Taak Co	Dr. Reza Mohammadi	Production of rich, low-fat mayonnaise enriched with vitamin D and prebiotics	9
2021	206/500/000	Gharb Kimia Co	Mr. Ahmad Tajeh Miri	Production of mycoprotein enriched with vitamin D	10
2021	200/000/000	Zarrin Kimia Co	Mr. Ahmad Tajeh Miri	Production of honey and Kermanshahi oil potion	11
2021	250/000/000	Safiran Daru Sarat Co	Dr. Leila Behbood	Preparation of anti-chronic cough pills based on Iranian traditional medicine sources	12
2021	800/000/000	Reyhaneh Isfahan Pharmaceutical Co	Dr. Gholamreza Bahrami	Bioequivalence study of ursodeoxycholic acid capsule product 300 mg of Reyhaneh Pharmaceutical Company of Isfahan (employer) in comparison with the reference product to renew the license of ursodeoxycholic acid capsule	13
2021	230/000/000	Forensic Research Center	Dr. Nazir Fattahi	Standardization of analytical methods for extraction and measurement of tricyclic antidepressants in post-mortem blood samples	14
2021	100/000/000	Petro Perima Zagros Co	Dr. Kambiz Varmira	A process to enrich urea chemical fertilizer and increase its durability in agricultural lands	15
2021	1/498/600/000	Kermanshah Province Water and Wastewater Company	Dr. Kiomars Sharafi - Dr. Amir Kiani	Evaluating the concentration and environmental risk associated with emerging pollutants (antibiotics and bisphenol A) in raw and treated wastewater in the cities of Sarpol Zahab, Islamabad Gharb and Qasr-e-Shirin and comparing the efficiency of activated sludge systems with extensive aeration, stabilization pond and reed synthetic in removing the mentioned compounds	16
2021	7/000/000/000	Vice Presidency of Science and Technology	Dr. Kamran Mansouri	Evaluating the effectiveness and safety of exosomes derived from placenta mesenchymal stem cells in improving the symptoms of lupus patients	17
2021	1/000/000/000	Delta Daru Pharmaceutical Company	Dr. Reza Tahvilian	Herbal children's anti-diarrhea suspension containing kaolin, pectin, ginger extract and oak extract	18
2021	231/150/000	Bu-Ali Daru Qom Pharmaceutical Co	Dr. Fatemeh Heiderpour	Effect of Ghost oil on diabetic neuropathy pain, A Double-blind Parallel-randomized Clinical Trial	19
2021	500/000/000	Biston Flour Company	Dr. Ehsan Sadeghi	Producing the prototype of bright multipurpose flour with high bran and improved nutritional properties	20

Table 3

2022	420/000/000	Ojan Sina Daru Pajuh Co	Dr. Seyed Shahram Mir Aghaei	Investigating the effect of a gel containing 10% frankincense extract in the treatment of hemorrhoids: a parallel, randomized clinical trial.	1
2022	200/000/000	Diba Gen Gostar Co	Dr. Soghra Bagheri	Investigating the effect of arsenic trioxide on the binding of fluorouracil to human serum albumin	2
2022	200/000/000	Kermanshah General Department of Education	Dr. Masoumeh Sadat Basam Tabaar	The effect of an innovative exercise program on the development of autistic children	3
2022	500/000/000	Paraman Co	Dr. Ehsan Sadeghi	Prototype production of beneficial tomato paste enriched with vitamins	4
2022	7/000/000/000	Vice Presidency of Science and Technology	Dr. Kamran Mansouri	Evaluating the effectiveness and safety of exosomes derived from placenta mesenchymal stem cells in improving the symptoms of lupus patients	5
2022	500/000/000	Gol Sahand Khosro Co	Dr. Farjam Goudarzi - Dr. Babak Haghshenas	Investigating the inhibitory effect of probiotic bacteria extract isolated from traditional dairy products on the differentiation of human mesenchymal stem cells into adipocytes	6
2022	200/000/000	Razi bio production company	Dr. Hamidreza Mohammadi Motlaq	Investigating the effectiveness and usefulness of topical gel containing pomegranate fruit peel extract in healing diabetic foot ulcers: a parallel, randomized, phase 2 clinical trial	7
2022	173/000/000	Safiran Daru Sarat Co	Dr. Mohammad Bagher Majnouni	Designing an oral formulation from the fruit of the oak tree (Quercus brantii) and evaluating its physicochemical properties to treat stomach ulcers and eradicate Helicobacter pylori.	8